Search Results - "Mambetsariev, Isa"

Small Cell Transformation of EGFR-Mutant NSCLC Treated with Tyrosine Kinase Inhibition.

Authors: Rock, Adam Mambetsariev, Isa Pareek, Siddhika et al.

Source: Current Oncology. Oct2025, Vol. 32 Issue 10, p554. 11p.

Current Clinical Paradigm and Therapeutic Advancements in Thymic Malignancies: A Narrative Review.

Authors: Dias e Silva, Douglas Miyamura, Beatriz Viesser Mambetsariev, Isa et al.

Source: Cancers. Nov2025, Vol. 17 Issue 22, p3622. 21p.

Clinical Network Systems Biology: Traversing the Cancer Multiverse.

Authors: Mambetsariev, Isa Fricke, Jeremy Gruber, Stephen B. et al.

Source: Journal of Clinical Medicine. Jul2023, Vol. 12 Issue 13, p4535. 13p.

A Closer Look at EGFR Inhibitor Resistance in Non-Small Cell Lung Cancer through the Lens of Precision Medicine.

Authors: Sattler, Martin Mambetsariev, Isa Fricke, Jeremy et al.

Source: Journal of Clinical Medicine. Mar2023, Vol. 12 Issue 5, p1936. 13p.

Pyramidal Decision Support Framework Leverages Subspecialty Expertise across Enterprise to Achieve Superior Cancer Outcomes and Personalized, Precision Care Plans.

Authors: Bosserman, Linda D. Mambetsariev, Isa Ladbury, Colton et al.

Source: Journal of Clinical Medicine. Nov2022, Vol. 11 Issue 22, p6738. 22p.

Precision medicine and actionable alterations in lung cancer: A single institution experience.

Authors: Mambetsariev, Isa Wang, Yingyu Chen, Chen et al.

Source: PLoS ONE. 2/11/2020, Vol. 15 Issue 2, p1-18. 18p.

Assessment of Barriers and Challenges to Screening, Diagnosis, and Biomarker Testing in Early-Stage Lung Cancer.

Authors: Zarinshenas, Reza Amini, Arya Mambetsariev, Isa et al.

Source: Cancers. Mar2023, Vol. 15 Issue 5, p1595. 11p.

Post-crizotinib management of effective ceritinib therapy in a patient with ALK-positive non-small cell lung cancer.

Authors: Won, Brian Mambetsariev, Isa Salgia, Ravi

Source: BMC Cancer. 8/2/2016, Vol. 16, p1-5. 5p. 3 Diagrams.

Evaluation of Somatic Mutations in Solid Metastatic Pan-Cancer Patients.

Authors: Roosan, Moom R. Mambetsariev, Isa Pharaon, Rebecca et al.

Source: Cancers. Jun2021, Vol. 13 Issue 11, p2776. 1p.

Differential Distribution of Brain Metastases from Non-Small Cell Lung Cancer Based on Mutation Status.

Authors: Chen, Bihong T. Jin, Taihao Ye, Ningrong et al.

Source: Brain Sciences (2076-3425). Jul2023, Vol. 13 Issue 7, p1057. 11p.

Small Cell Lung Cancer Transformation following Treatment in EGFR-Mutated Non-Small Cell Lung Cancer.

Authors: Mambetsariev, Isa Arvanitis, Leonidas Fricke, Jeremy et al.

Source: Journal of Clinical Medicine. Mar2022, Vol. 11 Issue 5, p1429. 1p.

This result is not displayed to guests.
Login for full access.

Clinical and Molecular Features of KRAS-Mutated Lung Cancer Patients Treated with Immune Checkpoint Inhibitors.

Authors: Zhao, Dan Li, Haiqing Mambetsariev, Isa et al.

Source: Cancers. Oct2022, Vol. 14 Issue 19, p4933. 12p.

Stiffness-Activated GEF-H1 Expression Exacerbates LPS-Induced Lung Inflammation.

Authors: Mambetsariev, Isa Tian, Yufeng Wu, Tinghuai et al.

Source: PLoS ONE. Apr2014, Vol. 9 Issue 4, p1-12. 12p.

Complex Oncological Decision-Making Utilizing Fast-and-Frugal Trees in a Community Setting—Role of Academic and Hybrid Modeling.

Authors: Salgia, Ravi Mambetsariev, Isa Tan, Tingting et al.

Source: Journal of Clinical Medicine. Jun2020, Vol. 9 Issue 6, p1884. 1p.

Small Cell Lung Cancer Therapeutic Responses Through Fractal Measurements: From Radiology to Mitochondrial Biology.

Authors: Mambetsariev, Isa Mirzapoiazova, Tamara Lennon, Frances et al.

Source: Journal of Clinical Medicine. Oct2019, Vol. 8 Issue 10, p1038. 1p.

Non-Small Cell Lung Cancer from Genomics to Therapeutics: A Framework for Community Practice Integration to Arrive at Personalized Therapy Strategies.

Authors: Rajurkar, Swapnil Mambetsariev, Isa Pharaon, Rebecca et al.

Source: Journal of Clinical Medicine. Jun2020, Vol. 9 Issue 6, p1870. 1p.

Molecular and Clinical Features of Hospital Admissions in Patients with Thoracic Malignancies on Immune Checkpoint Inhibitors.

Authors: Zhao, Dan Li, Haiqing Mambetsariev, Isa et al.

Source: Cancers. Jun2021, Vol. 13 Issue 11, p2653. 1p.

Effective osimertinib treatment in a patient with discordant T790 M mutation detection between liquid biopsy and tissue biopsy.

Authors: Mambetsariev, Isa Vora, Lalit Yu, Kim Wai et al.

Source: BMC Cancer. 3/21/2018, Vol. 18, p1-1. 1p. 1 Black and White Photograph, 1 Diagram.

EPHA2 mutations with oncogenic characteristics in squamous cell lung cancer and malignant pleural mesothelioma.

Authors: Tan, Yi-Hung Carol Srivastava, Saumya Won, Brian M. et al.

Source: Oncogenesis. Sep2019, Vol. 8 Issue 9, pN.PAG-N.PAG. 1p.